Transthyretin Amyloid Cardiomyopathy Treatment Market Driven by...

agrega un archivo Other

2024-06-25 09:19:31 -

Transthyretin Amyloid Cardiomyopathy Treatment Market Driven by Increasing Prevalence of Cardiomyopathy

The Global Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1943.69 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031.Key players operating in the Transthyretin Amyloid Cardiomyopathy Treatment market are DermaSweep Inc., Lifetrons Switzerland AG, Trophy Skin, Silk€TMn, HoMedics USA LLC, PMD Beauty, Dermaglow,...

0 Commentarios 0 Acciones 80 Views 0 Vista previa